{
  "schemaVersion": 1,
  "id": "research-114",
  "slug": "114-how-to-read-the-posted-duchenne-results",
  "title": "How to read the posted Duchenne results",
  "catalogLabel": "Follistatin 344",
  "productCollection": "https://heritagebiolabs.com/research-library/products/follistatin-344",
  "productHandles": [
    "follistatin-344-426"
  ],
  "productUrls": [
    "https://heritagebiolabs.com/product/follistatin-344-426"
  ],
  "readingFocus": "Mechanisms & biology",
  "readingFocusNote": "Reading focus is a navigational tag, not an evidence grade.",
  "wordCount": 280,
  "sourceYears": [
    2020,
    2026
  ],
  "paragraphs": [
    "Peptides consist of short chains of amino acids linked by peptide bonds. Some interact with signals that influence muscle growth. Follistatin is a much larger protein. FST344 is the name of the longer precursor, and it also appears in the name of an investigational gene transfer intervention studied in Duchenne muscular dystrophy. The results posted in 2020 offer a separate clinical observation from the earlier Becker study. [1] [2]",
    "The Duchenne study's public results show that three participants completed it. The registry lists outcomes for safety and movement. It reports that none of the three met the recorded criterion of increased distance on the six-minute walk test, and one of three met the improvement criterion on the North Star Ambulatory Assessment. That assessment considers several tasks, so its result can differ from a test of how far a person walks. The record also shows zero events meeting the study's specified category for toxicity that would limit exposure. That category is narrower than all adverse events. [1]",
    "The registry gives counts as well as descriptions of the outcomes. Both matter. A result for one person is a third of a group this small. There was one study group, so the counts cannot estimate how the participants would have changed over the same interval under comparable care without the study intervention. A completed record provides documented observations rather than a reliable estimate of clinical benefit. [1]",
    "The findings pertain to an investigational gene therapy in a small Duchenne study. They do not represent a clinical test of a finished product containing follistatin protein. The registry identifies the intervention and shows why the distinction matters for interpreting what was actually studied. [1] [2]"
  ],
  "sources": [
    {
      "number": 1,
      "citation": "Nationwide Children's Hospital. Phase I/II Clinical Intramuscular Gene Transfer of rAAV1.CMV.huFollistatin344 Trial to Patients With Duchenne Muscular Dystrophy. ClinicalTrials.gov (publication 2020-04-15).",
      "url": "https://clinicaltrials.gov/study/NCT02354781?tab=results"
    },
    {
      "number": 2,
      "citation": "National Center for Biotechnology Information. FST follistatin [Homo sapiens (human)]. NCBI Gene (publication 2026-10-14).",
      "url": "https://www.ncbi.nlm.nih.gov/gene/10468"
    }
  ],
  "canonicalUrl": "https://heritagebiolabs.com/research-library/articles/114-how-to-read-the-posted-duchenne-results",
  "markdownUrl": "https://heritagebiolabs.com/research-library/data/articles/114-how-to-read-the-posted-duchenne-results.md",
  "jsonUrl": "https://heritagebiolabs.com/research-library/data/articles/114-how-to-read-the-posted-duchenne-results.json",
  "provenance": {
    "sourceArchive": "Peptide Research Articles - All 82 Volumes.zip",
    "sourceArchiveSha256": "9796bec477cbe2f8017dda81c7e58260985a13bdda1f934e8eb8d0549c2cada5",
    "sourceVolume": "Peptide Research Articles 023 - Follistatin 344.docx",
    "sourceArticleNumber": 114,
    "contentSha256": "93be4f3543b448ca4a4fe9f75cecef3fd36d55becc401289999b4d6040c635ed",
    "statement": "Article titles, body paragraphs and numbered citations extracted without rewriting from owner-supplied Word volumes. Product mappings use exact catalog labels; reading-focus tags and excerpts are navigational metadata. No independent peer-review or comprehensive source verification is claimed."
  },
  "scope": "Educational article about published research. For research use only; not medical advice. Literature does not establish the identity, purity or activity of a purchased lot, and studies of individual components do not validate a blend."
}
